The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI.
Saved in:
| Title: | The FGFR inhibitor Rogaratinib reduces microglia reactivity and synaptic loss in TBI. |
|---|---|
| Authors: | Rehman R; Department of Neurology, Ulm University, Ulm, Germany.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States., Froehlich A; Department of Neurology, Ulm University, Ulm, Germany., Olde Heuvel F; Department of Neurology, Ulm University, Ulm, Germany., Elsayed L; Department of Neurology, Ulm University, Ulm, Germany., Boeckers T; German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany.; Institute of Anatomy and Cell biology, Ulm University, Ulm, Germany., Huber-Lang M; Institute of Translational Trauma Immunology, Ulm University, Ulm, Germany., Morganti-Kossmann C; Department of Child Health, Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ, United States.; University of Arizona College of Medicine, Phoenix, AZ, United States., Roselli F; Department of Neurology, Ulm University, Ulm, Germany.; German Center for Neurodegenerative Diseases (DZNE), Ulm, Germany. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Nov 20; Vol. 15, pp. 1443940. Date of Electronic Publication: 2024 Nov 20 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1443940 |
